We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPH
901
DELISTED
scPharmaceuticals
SCPH
$259K 0.01%
67,900
– –
RRBI icon
902
Red River Bancshares
RRBI
$665M
$259K 0.01%
4,407
– –
NATR icon
903
Nature's Sunshine
NATR
$353M
$257K 0.01%
17,379
-147
-0.8% -$1.99K
DC icon
904
Dakota Gold
DC
$718M
$256K 0.01%
69,400
-50,000
-42% -$156K
BIRD icon
905
Smartbird Inc
BIRD
$20.5M
$253K 0.01%
23,831
– –
KGEI
906
Kolibri Global Energy
KGEI
$172M
$252K 0.01%
36,771
+1,765
+5% +$12.1K
YMAB
907
DELISTED
Y-mAbs Therapeutics
YMAB
$251K 0.01%
55,700
+30,800
+124% +$138K
NRDY icon
908
Nerdy
NRDY
$105M
$249K 0.01%
152,800
– –
ALTG icon
909
Alta Equipment Group
ALTG
$243M
$249K 0.01%
39,400
– –
SCYX icon
910
SCYNEXIS
SCYX
$51.2M
$248K 0.01%
46,023
+1,837
+4% +$12.9K
WTI icon
911
W&T Offshore
WTI
$484M
$248K 0.01%
150,000
– –
CRGX
912
DELISTED
CARGO Therapeutics
CRGX
$247K 0.01%
+60,000
New +$257K
EHTH icon
913
eHealth
EHTH
$40M
$247K 0.01%
56,700
– –
CDXS icon
914
Codexis
CDXS
$156M
$246K 0.01%
100,908
+6,300
+7% +$14.8K
TECX
915
Tectonic Therapeutic
TECX
$558M
$246K 0.01%
12,383
-2,285
-16% -$46.3K
TRVI icon
916
Trevi Therapeutics
TRVI
$2.65B
$246K 0.01%
44,981
-35,000
-44% -$218K
AVD icon
917
American Vanguard Corp
AVD
$73.2M
$246K 0.01%
62,753
– –
STIM icon
918
Neuronetics
STIM
$164M
$245K 0.01%
70,205
+25,000
+55% +$98.7K
EGHT icon
919
8x8 Inc
EGHT
$328M
$245K 0.01%
125,000
+75,000
+150% +$132K
BDTX icon
920
Black Diamond Therapeutics
BDTX
$103M
$244K 0.01%
98,300
+25,200
+34% +$48.6K
SPIR icon
921
Spire Global
SPIR
$499M
$238K 0.01%
20,000
– –
INFU icon
922
InfuSystem Holdings
INFU
$245M
$236K 0.01%
37,900
-30,000
-44% -$166K
INBX icon
923
Inhibrx
INBX
$1.23B
$235K 0.01%
+16,500
New +$213K
VMD icon
924
Viemed Healthcare
VMD
$376M
$235K 0.01%
34,000
+7,500
+28% +$50.9K
ANNX icon
925
Annexon
ANNX
$880M
$235K 0.01%
+97,800
New +$196K
35 36
37
38 39

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.